首站-论文投稿智能助手
典型文献
Innate immune checkpoint Siglec10 in cancers:mining of comprehensive omics data and validation in patient samples
文献摘要:
Sialic acid binding Ig-like lectin 10(Siglec10)is a member of innate immune checkpoints that inhibits the activation of immune cells through the interaction with its ligand CD24 on tumor cells.Here,by analyzing public databases containing 64 517 patients of 33 cancer types,we found that the expression of Siglecl0 was altered in 18 types of cancers and was associated with the clinical outcomes of 11 cancer types.In particular,Siglec10 was upregulated in patients with kidney renal clear cell carcinoma(KIRC)and was inversely associated with the prognosis of the patients.In 131 KIRC patients of our settings,Siglec10 was elevated in the tumor tissues of 83(63.4%)patients compared with that in their counterpart normal kidney tissues.Moreover,higher level of Siglec10 was associated with advanced disease(stages Ⅲ and Ⅳ)and worse prognosis.Silencing of CD24 in KIRC cells significantly increased the number of Siglec10-expressing macrophages phagocytosing KIRC cells.In addition,luciferase activity assays suggested that Siglec10 was a potential target of the transcription factors c-FOS and GATA1,which were identified by data mining.These results demonstrate that Siglec10 may have important oncogenic functions in KIRC,and represents a novel target for the development of immunotherapies.
文献关键词:
作者姓名:
Chen Zhang;Jiandong Zhang;Fan Liang;Han Guo;Sanhui Gao;Fuying Yang;Hua Guo;Guizhen Wang;Wei Wang;Guangbiao Zhou
作者机构:
State Key Laboratory of Membrane Biology,Institute of Zoology,Chinese Academy of Sciences&University of Chinese Academy of Sciences,Beijing 100101,China;State Key Laboratory of Molecular Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Department of Urology,Beijing Chaoyang Hospital,Capital Medical University,Beijing 100020,China;Shanxi Bethune Hospital Affiliated with Shanxi Academy of Medical Sciences,Taiyuan 030032,China
文献出处:
引用格式:
[1]Chen Zhang;Jiandong Zhang;Fan Liang;Han Guo;Sanhui Gao;Fuying Yang;Hua Guo;Guizhen Wang;Wei Wang;Guangbiao Zhou-.Innate immune checkpoint Siglec10 in cancers:mining of comprehensive omics data and validation in patient samples)[J].医学前沿,2022(04):596-609
A类:
Siglec10,Siglecl0,phagocytosing
B类:
Innate,immune,cancers,mining,comprehensive,omics,validation,samples,Sialic,acid,binding,Ig,like,lectin,member,innate,checkpoints,that,inhibits,activation,cells,through,interaction,ligand,CD24,tumor,Here,by,analyzing,public,databases,containing,patients,types,found,expression,was,altered,associated,clinical,outcomes,particular,upregulated,kidney,renal,clear,carcinoma,KIRC,inversely,prognosis,our,settings,elevated,tissues,compared,their,counterpart,normal,Moreover,higher,level,advanced,disease,stages,worse,Silencing,significantly,increased,number,expressing,macrophages,addition,luciferase,activity,assays,suggested,potential,target,transcription,factors,FOS,GATA1,which,were,identified,These,results,demonstrate,may,have,important,oncogenic,functions,represents,novel,development,immunotherapies
AB值:
0.5354
相似文献
Paired box 5 increases the chemosensitivity of esophageal squamous cell cancer cells by promoting p53 signaling activity
Zhang Weiwei;Yan Wenji;Qian Niansong;Han Quanli;Zhang Weitao;Dai Guanghai-Chinese People’s Liberation Army Medical School, Beijing 100853, China;Department of the Third Health Care, The Second Medical Center, Chinese People’s Liberation Army General Hospital, Beijing 100853, China;Department of Oncology, The First Medical Center, Chinese People’s Liberation Army General Hospital, Beijing 100853, China;Department of Oncology, The Hainan Medical Center, Chinese People’s Liberation Army General Hospital, Sanya 572022, China;Cancer Center, Beijing Tongren Hospital Affiliated to Capital Medical University, Economic and Technological Development Zone, Beijing 100176, China
Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1
Li Mingzhe;Zhou Jiaxin;Zhang Zhengkui;Li Jisong;Wang Feng;Ma Ling;Tian Xiaodong;Mao Zebin;Yang Yinmo-Department of General Surgery, Peking University First Hospital, Beijing 100034, China;Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang 310016, China;Department of Gastrointestinal Surgery, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, Sichuan 610072, China;Department of Surgical Oncology, Peking University Ninth School of Clinical Medicine (Beijing Shijitan Hospital, Capital Medical University), Beijing 100038, China;Department of Medical Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing 100191, China
TMEM106A transcriptionally regulated by promoter methylation is involved in invasion and metastasis of hepatocellular carcinoma
Shiming Shi;Biao Wang;Jinglei Wan;Lina Song;Guiqi Zhu;Junxian Du;Luxi Ye;Qianqian Zhao;Jialiang Cai;Qing Chen;Kun Xiao;Jian He;Lei Yu;Zhi Dai-Liver Cancer Institute,Zhongshan Hospital,Fudan University&State Key Laboratory of Genetic Engineering,Fudan University,Shanghai 200032,China;Department of Radiation Oncology,Zhongshan Hospital,Fudan University,Shanghai 200032,China;Department of Pediatric Surgery,the First Affiliated Hospital of Sun Yat-sen University,Guangzhou 510080,China;Department of General Surgery,Zhongshan Hospital(South),Fudan University,Shanghai Public Health Clinical Center,Fudan University,Shanghai 200083,China;Department of Gastrointestinal Surgery,Shandong Provincial Hospital Affiliated to Shandong First Medical University,Jinan 250021,China;Department of Liver Surgery and Transplantation,Liver Cancer Institute,Zhongshan Hospital,Fudan University,Shanghai 200032,China
Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+T cell-mediated ferroptosis in castration-resistant prostate cancer
Xumin Zhou;Libin Zou;Hangyu Liao;Junqi Luo;Taowei Yang;Jun Wu;Wenbin Chen;Kaihui Wu;Shengren Cen;Daojun Lv;Fangpeng Shu;Yu Yang;Chun Li;Bingkun Li;Xiangming Mao-Department of Urology,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Second Department of Hepatobiliary Surgery,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Department of Urology,Minimally Invasive Surgery Center,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510120,China;Department of Urology,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China;Department of Urology,Peking University Shenzhen Hospital,Shenzhen 518036,China;Nursing Department,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China
NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury
Zhi-yong Xie;Wei Dong;Li Zhang;Meng-jie Wang;Zhen-meng Xiao;Yu-hua Zhang;Wan-xin Shi;Ying Huang;Yan Yang;Cui-li Li;Lei Fu;Xing-chen Zhao;Rui-zhao Li;Zhi-lian Li;Yuan-han Chen;Zhi-ming Ye;Shuang-xin Liu;Zheng Dong;Xin-ling Liang-The Second School of Clinical Medicine,Southern Medical University,Guangzhou 510515,China;Division of Nephrology,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China;School of Medicine,South China University of Technology,Guangzhou 510006,China;Department of Cellular Biology and Anatomy,Medical College of Georgia at Augusta University,Augusta,GA,USA;Department of Medical Research,Charlie Norwood Veterans Affairs Medical Center,Augusta,GA,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。